Immuno-oncology has continued to be a priority for Big Pharma even during the heights of the Covid pandemic. Commetric’s infographic looks at the media debate around this rapidly developing field, taking into account key topics, companies, spokespeople, journalists and media outlets.
Recent Posts
- From product to process: how the FMCG sustainability communications evolved
- The road to IPO: how fintechs are building new maturity narratives
- Why we fear chemicals – and why the chemical sector needs a new PR formula
- New Commetric AI-powered analytics range promises ‘no limit’ media insights at low cost
- ESMO 2024’s PR takeaway: immunotherapy roars back, but it needs reframing
Tags
AI
AMEC
Awards
Brand management
Climate Change
Consumer Trends
Corporate Communication
Corporate Reputation
COVID-19 Business Impact Tracker
Crisis Communications
Crisis Management
Digital Marketing
ESG
Facebook
Fashion
Financial Services
Food and Drink
Health & Wellness
Health and Wellness
Immunotherapy
Influencer Marketing
Influencer Network Analysis
Instagram
Media Analytics
Media Intelligence
Media Monitoring
Net Zero
Oncology
Pharma
PR
Precision Medicine
PR Measurement
PR Strategy
Public Affairs
Public Relations
Regeneration
Reputation Management
Social Media
Social Media Analytics
Social Media Marketing
Storytelling
Strategic Communications
Sustainability
Tech
Twitter